
Palatine sells Chase Templeton to Nevada
Palatine Private Equity has sold UK-based private medical insurance provider Chase Templeton to Nevada Investments.
Under the vendor's four-year tenure, the business undertook an acquisitive growth strategy, completing 75 transactions and increasing its revenues from £90m to £150m.
Throughout the course of 2016, Chase Templeton acquired Southport-based competitor Ultimate Health, Manchester-based Wellbeing Health Insurance, Leeds-based Independent Health Insurance Services, Preston-based Health Equity Solutions and Kelso-based Caledonian Health Solutions.
Chase Templeton was the maiden investment from Palatine's second fund, which held a final close on its £150m hard-cap in July 2013.
A spokesperson for the vendor declined to comment on the deal valuation or returns generated from the sale.
Previous funding
Palatine acquired Chase Templeton in February 2013. The value of the deal was undisclosed, though the GP's second fund typically made equity investments between £10-25m.
Company
Headquartered in Darwen, Lancashire, and founded in 2002, Chase Templeton is a provider of private medical insurance.
People
Palatine Private Equity – Ed Fazakerley (partner).
Chase Templeton – Warren Dickson (CEO).
Advisers
Vendor – Deloitte, Olly Tebbutt, Simon Barrass, Myles Philips (corporate finance); Gateley, Rebecca Grisewood, Steve Roberts (legal); PwC, Jonathan Cooper, Syd Hussain (financial due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater